pharmaglobenews

The global oxygen therapy equipment market is witnessing substantial growth, fueled by the rising prevalence of respiratory disorders, increasing use in critical care settings, and rapid technological advancements. The growing incidence of chronic lung diseases such as COPD and asthma has heightened

The food allergy market is projected to experience significant growth in the coming years, driven by the adoption of recently approved therapies and promising emerging treatments such as Viaskin (DBV712) Peanut Patch (DBV Technologies), PVX108 (Aravax), Remibrutinib (Novartis), SLIT tablet (ALK-Abello), RPT904

The choroidal neovascularization therapeutics market is anticipated to grow further, driven by key factors such as the increasing prevalence of the condition, technological advancements, and emerging therapies—including AbbVie and REGENXBIO’s ABBV-RGX-314, Adverum Biotechnologies’ Ixoberogene soroparvovec, Neuracle Genetics’ NG101, and others—over the forecast

The pain management devices market is projected to witness significant growth from 2025 to 2032, driven by the rising prevalence of chronic pain, ongoing product innovations, and heightened awareness of treatment options. Increasing demand for minimally invasive solutions, alongside the influence of

The diffuse large B-cell lymphoma (DLBCL) market was valued at USD 4.7 billion across the leading markets (the US, EU4, UK, and Japan) in 2024. In the United States, the market is projected to exceed USD 11.5 billion by 2034, driven by

The demand for digital biomarkers is rising rapidly, driven primarily by the global increase in chronic diseases, including cardiovascular, neurological, and metabolic disorders. This growth is further supported by the expanding elderly population, which is more vulnerable to age-related health conditions. Additionally,